Printer Friendly

Articles from M2 Pharma (September 18, 2018)

1-27 out of 27 article(s)
Title Author Type Words
Actelion Pharmaceuticals reveals results of first randomised controlled trial in portopulmonary hypertension. 141
Agenus awarded USD5m in milestone payment for initiation of Phase 1 trial of LAG-3 antibody. 148
American Associated Pharmacies closes acquisition of remaining 50% stake in Arete Pharmacy Network LLC. 218
AmpliPhi Biosciences Claims Positive FDA Feedback for its Clinical Stage Bacteriophage Product Candidate AB-SA01. 600
AmpliPhi Biosciences Updates Positive Clinical Results for its Expanded Access Programme. 485
CBR Touts Positive Results for First Study Administering Cord Blood to Children with Hearing Loss. 342
FDA Grants Lin BioScience Rare Pediatric Disease Status for LBS-008 to Treat Stargardt Disease. 303
Halozyme wins Canadian approval for subcutaneous formulation of trastuzumab (Herceptin SC) for treating breast cancer. 186
ITM and Merck KGaA Sign Research Evaluation and Option Agreement to Develop Folate Receptor Targeted Radionuclide Therapy. 386
Lin BioScience announces US FDA RPD designation for LBS-008 to treat Stargardt Disease. 228
Lin BioScience receives Rare Pediatric Disease designation from US FDA for LBS-008. 235
Navidea Biopharmaceuticals completes USD3m in private placement. 129
Nemaura Inks License Agreement for 3 New Transdermal Patch Developments, and 48 Hour Diclofenac Patch Debut at CPhI Madrid. 359
Oramed wins US FDA clearance for IND application for ORMD-0901 to treat type 2 diabetes. 198
ORIC Pharmaceuticals names new chief medical officer. 253
Positive Cytisine Data Published in International Journal of Drug Policy. 384
Sebacia awarded US FDA clearance for Sebacia Microparticles acne treatment. 221
Sensus Healthcare raises USD15m from public offering. 193
Sinclair Pharma agrees to potential offer from Huadong. 175
Supernus agrees to acquire Biscayne Neurotherapeutics. 222
Tikcro Technologies incurs lower net loss of USD341,000 for Q2 2018. Financial report 169
Tzianabos Named to Stoke Therapeutics Board of Directors. 317
US FDA approves Oramed Pharmaceuticals' Investigational New Drug application for human trials of ORMD-0901. 169
US Food and Drug Administration grants approval to Teva Pharmaceutical's AJOVY. 200
Valeo Pharma and Besins Healthcare Partner for Utrogestan in Canada. 254
WAT Medical Enterprise wins US FDA clearance for HeadaTerm to treat migraine headache. 256
Wolters Kluwer Highlights Patients as Underutilised Resource in the Fight against Sepsis. 487

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters